147 related articles for article (PubMed ID: 32935413)
1. Influence of end stage renal disease on CD28 expression and T-cell immunity.
Sampani E; Stangou M; Daikidou DV; Nikolaidou V; Asouchidou D; Dimitriadis C; Lioulios G; Xochelli A; Fylaktou A; Papagianni A
Nephrology (Carlton); 2021 Feb; 26(2):185-196. PubMed ID: 32935413
[TBL] [Abstract][Full Text] [Related]
2. CD28null and Regulatory T Cells Are Substantially Disrupted in Patients with End-Stage Renal Disease Due to Diabetes Mellitus.
Sampani E; Daikidou DV; Lioulios G; Xochelli A; Mitsoglou Z; Nikolaidou V; Dimitriadis C; Fylaktou A; Papagianni A; Stangou M
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33804135
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D deficiency, CD4+CD28null cells and accelerated atherosclerosis in chronic kidney disease.
Yadav AK; Banerjee D; Lal A; Jha V
Nephrology (Carlton); 2012 Aug; 17(6):575-81. PubMed ID: 22489804
[TBL] [Abstract][Full Text] [Related]
4. Naïve and central memory T-cell lymphopenia in end-stage renal disease.
Yoon JW; Gollapudi S; Pahl MV; Vaziri ND
Kidney Int; 2006 Jul; 70(2):371-6. PubMed ID: 16738532
[TBL] [Abstract][Full Text] [Related]
5. CD4+CD28null cells are expanded and exhibit a cytolytic profile in end-stage renal disease patients on peritoneal dialysis.
Yadav AK; Jha V
Nephrol Dial Transplant; 2011 May; 26(5):1689-94. PubMed ID: 21382991
[TBL] [Abstract][Full Text] [Related]
6. The difference of T cell phenotypes in end stage renal disease patients under different dialysis modality.
Xiaoyan J; Rongyi C; Xuesen C; Jianzhou Z; Jun J; Xiaoqiang D; Xiaofang Y
BMC Nephrol; 2019 Aug; 20(1):301. PubMed ID: 31383007
[TBL] [Abstract][Full Text] [Related]
7. Circulating CD4+CD28null and extra-thymic CD4+CD8+ double positive T cells are independently associated with disease damage in systemic lupus erythematosus patients.
Ugarte-Gil MF; Sánchez-Zúñiga C; Gamboa-Cárdenas RV; Aliaga-Zamudio M; Zevallos F; Tineo-Pozo G; Cucho-Venegas JM; Mosqueira-Riveros A; Medina M; Perich-Campos RA; Alfaro-Lozano JL; Rodriguez-Bellido Z; Alarcón GS; Pastor-Asurza CA
Lupus; 2016 Mar; 25(3):233-40. PubMed ID: 26385221
[TBL] [Abstract][Full Text] [Related]
8. Electrolysed-reduced water dialysate improves T-cell damage in end-stage renal disease patients with chronic haemodialysis.
Huang KC; Hsu SP; Yang CC; Ou-Yang P; Lee KT; Morisawa S; Otsubo K; Chien CT
Nephrol Dial Transplant; 2010 Aug; 25(8):2730-7. PubMed ID: 20190245
[TBL] [Abstract][Full Text] [Related]
9. CMV seropositivity determines epoetin dose and hemoglobin levels in patients with CKD.
Betjes MG; Weimar W; Litjens NH
J Am Soc Nephrol; 2009 Dec; 20(12):2661-6. PubMed ID: 19820127
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of circulating CD4+CD28null T cells is associated with early atherosclerotic damage in patients with end-stage renal disease undergoing hemodialysis.
Sun Z; Ye H; Tang B; Shen X; Wu X; Zhong H; Song W
Hum Immunol; 2013 Jan; 74(1):6-13. PubMed ID: 22902395
[TBL] [Abstract][Full Text] [Related]
11. High numbers of differentiated CD28null CD8+ T cells are associated with a lowered risk for late rejection and graft loss after kidney transplantation.
Betjes MGH; Litjens NHR
PLoS One; 2020; 15(2):e0228096. PubMed ID: 32023273
[TBL] [Abstract][Full Text] [Related]
12. Atherosclerosis in rheumatoid arthritis: associations between anti-cytomegalovirus IgG antibodies, CD4+CD28null T-cells, CD8+CD28null T-cells and intima-media thickness.
Wahlin B; Fasth AER; Karp K; Lejon K; Malmström V; Rahbar A; Wållberg-Jonsson S; Södergren A
Clin Exp Rheumatol; 2021; 39(3):578-586. PubMed ID: 32896254
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus contributes partly to uraemia-associated premature immunological ageing of the T cell compartment.
Meijers RW; Litjens NH; de Wit EA; Langerak AW; van der Spek A; Baan CC; Weimar W; Betjes MG
Clin Exp Immunol; 2013 Dec; 174(3):424-32. PubMed ID: 23962178
[TBL] [Abstract][Full Text] [Related]
14. Between adaptive and innate immunity: TLR4-mediated perforin production by CD28null T-helper cells in ankylosing spondylitis.
Raffeiner B; Dejaco C; Duftner C; Kullich W; Goldberger C; Vega SC; Keller M; Grubeck-Loebenstein B; Schirmer M
Arthritis Res Ther; 2005; 7(6):R1412-20. PubMed ID: 16277694
[TBL] [Abstract][Full Text] [Related]
15. Expanded peripheral CD4
Okba AM; Abd El Raouf Raafat M; Nazmy Farres M; Abd El Nour Melek N; Amin MM; Gendy NN
Hum Immunol; 2019 Sep; 80(9):748-754. PubMed ID: 30853362
[TBL] [Abstract][Full Text] [Related]
16. End stage renal disease has an early and continuous detrimental effect on regulatory T cells.
Sampani E; Vagiotas L; Daikidou DV; Nikolaidou V; Xochelli A; Kasimatis E; Lioulios G; Dimitriadis C; Fylaktou A; Papagianni A; Stangou M
Nephrology (Carlton); 2022 Mar; 27(3):281-287. PubMed ID: 34781412
[TBL] [Abstract][Full Text] [Related]
17. Continuous ambulatory peritoneal dialysis improves both the number and memory function of CD4 T cells in uremic patients.
Chansritrakul S; Eiam-Ong S; Kansanabuch T; Wathanavaha A; Ruxrungtham K
J Med Assoc Thai; 2004 Apr; 87(4):389-94. PubMed ID: 15217176
[TBL] [Abstract][Full Text] [Related]
18. Killer cell immunoglobulin receptor profile on CD4(+) CD28(-) T cells and their pathogenic role in non-dialysis-dependent and dialysis-dependent chronic kidney disease patients.
Zal B; Chitalia N; Ng YS; Trieu V; Javed S; Warrington R; Kaski JC; Banerjee D; Baboonian C
Immunology; 2015 May; 145(1):105-13. PubMed ID: 25484131
[TBL] [Abstract][Full Text] [Related]
19. Peritonitis outcomes in patients with HIV and end-stage renal failure on peritoneal dialysis: a prospective cohort study.
Ndlovu KC; Sibanda W; Assounga A
BMC Nephrol; 2017 Feb; 18(1):48. PubMed ID: 28158991
[TBL] [Abstract][Full Text] [Related]
20. The expression of molecule CD28 and CD38 on CD4⁺/CD8⁺ T lymphocytes in thymus and spleen elicited by Schistosoma japonicum infection in mice model.
Li N; Ji PY; Song LG; Lei JX; Lv ZY; Wu ZD; Shao X; Sun X
Parasitol Res; 2015 Aug; 114(8):3047-58. PubMed ID: 26002824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
